To end HIV/AIDS and TB, we need to ‘equalize’ global commitment, financial resources and attention between the two diseases.

Pune-based diagnostic kit manufacturer Mylab Discovery Solutions has launched India’s first indigenously developed Tuberculosis detection kit. The PathoDetect kit can also detect multiple drug resistance to Rifampicin and Isoniazid in a single test. TB is one of the biggest killers in India with 4.93 lakh deaths reported in 2020.

Hanoi (VNS/VNA) - A team of 23 scientists from different hospitals and institutes has conducted a massive scientific research project to help control tuberculosis (TB).

Gross anatomy reveals three-dimensional shapes of pathology at a large scale. Histology, in contrast, reveals the microscopic anatomy of biological structures. But that magnification comes at a cost — histology shows only two-dimensional shapes because it studies small, flat slices of stained tissue.

South African prisons are famously overcrowded. Prison populations are believed to exceed capacity by an overall 33%, although that number jumps to over 200% at some facilities, according to recent reports.

Once considered a potentially static field of medicine, the discipline of studying infectious diseases has proven to be dynamic as emerging and reemerging infectious diseases present continuous challenges, Anthony S. Fauci, M.D., writes in a perspective in the New England Journal of Medicine. In the piece, Dr. Fauci, who since 1984 has directed the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, reflects on his career responding to infectious disease threats. Dr. Fauci will step down from his positions as NIAID director, chief of NIAID’s Laboratory of Immunoregulation and chief medical advisor to President Joe Biden in December 2022.

Our health systems endured a heavy – often invisible – cost during the COVID-19 pandemic. While the country was focused on the battle against this pandemic, long-fought gains against other infectious diseases were being rolled back.

Some strains of the TB bacterium have mutated to become resistant to some of the drugs commonly used to treat TB. Accordingly, one of the first questions to ask when someone has TB is which drugs will be effective in fighting that person’s TB. Unfortunately, quick answers to this question are not always available. As a consequence, people are at times treated with drugs that won’t work for their particular strain of TB. What’s worse, these drugs often have significant side effects.

A study published in The Lancet Global Health evaluated the impact of COVID-19 on child TB notifications, suggesting that COVID-19 has substantially affected childhood TB services, with the youngest children most affected.

The World Health Organization will host a webinar on 28 November 2022 to introduce the Framework for Collaborative Action on Tuberculosis and Comorbidities.